Entering text into the input field will update the search result below

ANI acquires lithium drug from Noven

Jul. 01, 2014 11:25 AM ETANI Pharmaceuticals, Inc. (ANIP) StockBy: Douglas W. House, SA News Editor
  • ANI Pharmaceuticals (NASDAQ:ANIP +5.4%) acquires Noven Therapeutics' NDA for Lithobid (lithium carbonate extended release 300 mg tablets) for an $11M upfront payment plus a $1M future milestone payment. ANI intends to launch the product under its own label in July. Previously, ANI contract manufactured the product for Noven.

Recommended For You

More Trending News

About ANIP Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ANIP--
ANI Pharmaceuticals, Inc.